Skip to main content
OpenTrials
Completed

NCT Number: NCT04371692

Prevalence of COVID-19 Infection Among HCW in a French University Hospital

The objective of this study is to determine the prevalence of SARS-Cov2 infection among health care workers exposed of Lille University Hospital, to describe its evolution during the epidemic taking into account the influence of occupational and environmental exposure determinants.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Hop Claude Huriez Chu Lille

Lille, 59037, France

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Health Care workers with or without symptoms suggestive of a COVID-19 infection

Exclusion criteria

  • HCW working off-site at the CHU de Lille
  • HCW on sick leave.
  • HCW outside the Lille University Hospital temporarily coming as reinforcements in the context of the epidemic.

Treatment and study plan

Self-Administered Questionnaire

Other

Every weeks during 2 months, clinical and occupational questionnaire are performed among a cohort of HCW exposed to covid occupational exposure

Other names: a specifically designed self-administered questionnaire

SARS-Cov2 testing

Diagnostic Test

Every weeks during 2 month, SARS-Cov2 RT-PCR, serological testing are performed among a cohort of HCW exposed to covid occupational exposure

Primary outcomes

  1. the prevalence of SARS- Cov2 infection Health Care Worker with or without symptoms suggestive of a COVID-19 infection

    Time frame: at 2 months

Secondary outcomes

  1. the prevalence of SARS- Cov2 infection Health Care Worker with or without symptoms suggestive of a COVID-19 infection

    Time frame: once week during 2 months

  2. Occupational exposures associated with the SARS-Cov2 infection

    Time frame: once week during 2 months

  3. Environmental exposures associated with the SARS-Cov2 infection

    Time frame: once week during 2 months

  4. immunologic status of health Care Worker

    Time frame: once week during 2 months

  5. inflammatory biomarkers status of Health Care Worker

    Time frame: once week during 2 months

Sponsors and collaborators

Lead sponsor

University Hospital, Lille

Other

Collaborators

  • Fondation Santé Roquette

Registry information

Official study title

Prevalence of SARS-Cov2 Infection Among HCW in Lille University Hospital

Acronym: EXPOCOVIA

Important dates

Study start
2020
Primary completion
2020
Study completion
2020
First posted
May 1, 2020
Registry last updated
Apr 23, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.